Johnson & Johnson (JNJ) Stock

Johnson & Johnson (JNJ) is a Healthcare stock trading at $228.38 (as of 2026-06-18), with a market capitalization of $542.42B and a trailing P/E of 26.1. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Johnson & Johnson and its subsidiaries operate in healthcare, developing, manufacturing, and selling products worldwide. Its remaining activities are organized around Innovative Medicine for prescription therapies, and MedTech for medical devices and related solutions, serving hospitals, healthcare professionals, wholesalers, and retailers.

Valuation — source: SEC EDGAR (first-party)
Price$228.38
Market Cap$542.42B
P/E Ratio26.1
EV / EBITDA17.6
Price / Book6.68
Price / Sales5.63
DCF Value (model)$125.51
DCF Upside vs Price-45.0%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$94.19B
Net Margin28.5%
Return on Equity25.9%
Debt / Equity0.68
Current Ratio1.03
Revenue Growth (YoY)9.9%
EPS Growth (YoY)-52.5%
FCF Growth (YoY)-56.6%
Financial Health — source: SEC EDGAR
Altman Z-Score5.02 (safe)
Piotroski F-Score3/9 (weak)
Valuation vs Sector & Industry
Stock P/E26.1
Sector P/E (Healthcare)21.0
Industry P/E (Pharmaceutical Products)17.3
vs Sector24.6%
vs Industry51.3%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Insider Buys (12mo)1
Insider Sells (12mo)3
Top Institutional HolderBlackRock, Inc. ($52.16B)
Institutional Holders Tracked10
Congressional Trades (recent)10
Company
SectorHealthcare
IndustryPharmaceutical Products
CEOJoaquin Duato
Employees138,100
CountryUS
IPO Date1943-01-02

Related Companies (Business model: Big Pharma / Branded Drugs + Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

  • Eli Lilly and Company (LLY)
  • AbbVie Inc. (ABBV)
  • Merck & Co., Inc. (MRK)
  • Abbott Laboratories (ABT)
  • Intuitive Surgical, Inc. (ISRG)
  • Amgen Inc. (AMGN)
  • Danaher Corporation (DHR)
  • Gilead Sciences, Inc. (GILD)
JNJ earnings history · JNJ institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.